PBPaweł Jan Babiński

Paweł Jan Babiński

*This is an algorithmically generated author record based on publicly available information.

Paweł Jan Babiński has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    TRAUMATIC BRAIN INJURIES IN SPORT – A REVIEW OF CURRENT KNOWLEDGE ON PREVENTION, DIAGNOSIS AND TREATMENT

    by Klaudia Płudowska, Jan Puliński, Martyna Balczyńska, Paweł Babiński, Paulina Lewaśkiewicz, Karol Sikora, Martyna Gładysz, Aleksander Kopczyński, Wiktoria Osztreicher, Anita Jalali

    Sport-related traumatic brain injuries (SR TBI) represent a significant public health issue, the importance of which continues to grow alongside the global increase in recreational physical activity. Projections indicate that the incidence of traumatic brain injuries (TBI) will remain high through 2025, potentially reaching up to 70 million cases annually. TBI not only results in acute neurological symptoms, including the potentially fatal second impact syndrome, but can also lead to severe long-term consequences such as chronic traumatic encephalopathy (CTE). Understanding the pathophysiological mechanisms, epidemiology, and available diagnostic and therapeutic strategies is crucial for reducing risk and improving treatment outcomes of these injuries.

  • Open Access

    SEMAGLUTIDE IN THE TREATMENT OF OBESITY- A NEW LOOK AT AN EFFECTIVE PHARMACOLOGICAL TOOL IN THE FIGHT AGAINST EXCESSIVE BODY WEIGHT

    by Monika Rogowska, Paulina Lewaśkiewicz, Karolina Wojdat-Krupa, Paweł Babiński, Filip Lachowski

    Obesity is a chronic and progressive disease, the prevalence of which continues to rise worldwide, leading to a worsening quality of life, increased incidence of other diseases, and mortality. Treating obesity poses many challenges in daily clinical practice, therefore requiring a comprehensive medical approach that involves not only lifestyle changes but also pharmacotherapy and the use of bariatric surgery methods. Due to the ongoing exploration of obesity-related issues, therapy with semaglutide, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class, has gained popularity, recently approved for treating obesity. Numerous clinical studies and observations have demonstrated that semaglutide has the most significant impact on weight loss among all drugs used in obesity therapy, accompanied by improvements in quality of life and cardiovascular risk factors. The aim of this article is to present the current state of knowledge regarding the use of semaglutide in obesity therapy, its safety, and its correlation with other obesity treatment methods. In this article, we used English databases such as PubMed, Google Scholar and Medline. We selected articles based on keywords such as semaglutide, glucagon-like peptide –1, obesity treatment, weight loss.

  • Open Access

    ARTHROSCOPY-ASSISTED VERSUS CONVENTIONAL FIXATION OF INTRA-ARTICULAR FRACTURES: A NARRATIVE REVIEW OF JOINT-SPECIFIC OUTCOMES

    by Krzysztof Chmura, Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina JęDrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Adrianna Alicja Piekarska, Gabriela Kryger

    Arthroscopy-assisted fracture fixation has increasingly been adopted as an adjunct to conventional open reduction and internal fixation (ORIF) in the management of intra-articular fractures. While ORIF remains the standard surgical approach, arthroscopy enables direct visualization of articular surfaces and associated intra-articular pathology, potentially improving reduction accuracy and clinical outcomes. This narrative review compares functional and clinical outcomes of conventional fixation techniques with arthroscopy-assisted approaches across multiple joints, including the ankle, knee (tibial plateau), wrist (distal radius), and elbow. A comprehensive literature search was conducted using PubMed and supplemented by systematic reviews from Embase and Cochrane databases. Current evidence demonstrates that arthroscopy-assisted fixation provides joint- and fracture-specific advantages, particularly in ankle fractures, Schatzker I–III tibial plateau fractures, and complete intra-articular distal radius fractures. Evidence for elbow fractures remains limited but suggests potential benefits in carefully selected cases. Arthroscopy-assisted fixation should be considered a complementary technique and applied selectively based on fracture morphology, joint involved, and surgeon expertise.

  • Open Access

    LIVER RESECTION VERSUS RADIOFREQUENCY ABLATION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA: AN EVIDENCE-BASED NARRATIVE REVIEW OF ONCOLOGICAL OUTCOMES AND TREATMENT SELECTION

    by Gabriela Kryger, Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina JęDrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska

    Background: Surgical resection (LR) and radiofrequency ablation (RFA) are established curative options for early-stage hepatocellular carcinoma (HCC), yet their relative benefits remain debated, particularly regarding long-term survival, recurrence control, and patient selection. Objectives: To synthesize contemporary evidence comparing liver resection and radiofrequency ablation for early-stage HCC, with a focus on oncological outcomes, recurrence patterns, perioperative safety, and clinically relevant subgroups. Methods: An evidence-based narrative review was conducted using structured searches of PubMed/MEDLINE and the Cochrane Library. Systematic reviews, meta-analyses, randomized controlled trials, and high-quality observational studies comparing LR and RFA in early-stage HCC were included. Outcomes of interest comprised overall survival (OS), recurrence-free or disease-free survival (RFS/DFS), tumor recurrence, perioperative morbidity, and cost-effectiveness. Findings were synthesized qualitatively. Results: Randomized controlled trials consistently demonstrated no statistically significant difference in overall survival between LR and RFA. In contrast, meta-analyses and propensity-adjusted observational studies suggested improved long-term survival following resection in selected patients with preserved liver function. Across comparative studies, recurrence-free survival and local tumor control consistently favored resection. Subgroup analyses indicated comparable survival outcomes between modalities in patients with very small tumors, impaired hepatic reserve (Child–Pugh class B), and elderly populations, while tumor size and anatomical location emerged as key modifiers of treatment efficacy. Conclusions: Liver resection provides superior local tumor control, whereas overall survival remains largely comparable between modalities in carefully selected patients. Treatment selection should be individualized, integrating tumor characteristics, liver function, patient comorbidities, and procedural risk within a multidisciplinary framework.

  • Open Access

    BIOLOGIC AND TARGETED THERAPIES IN ATOPIC DERMATITIS: A BIOMARKER-INFORMED FRAMEWORK FOR PERSONALIZED TREATMENT SELECTION

    by Zuzanna Karolina JęDrzejczak, Paweł Jan Babiński, Magdalena Wiśniewska, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger

    Background: Atopic dermatitis is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and impaired quality of life. Advances in understanding type 2 immune dysregulation have led to the development of biologic and targeted systemic therapies; however, treatment response remains heterogeneous, highlighting the need for personalized therapeutic strategies. Objective: To review current biologic and targeted systemic therapies for moderate-to-severe atopic dermatitis, examine the role of clinical and molecular biomarkers in predicting treatment response, and propose a biomarker-informed framework for personalized treatment selection. Methods: A narrative review was conducted of literature published between January 2020 and July 2024 using major scientific databases. Included publications comprised randomized controlled trials, cohort studies, systematic reviews, and expert consensus documents addressing systemic therapies, biomarker associations, and stratified treatment approaches in atopic dermatitis. Results: Biologic agents, including dupilumab, tralokinumab, lebrikizumab, and nemolizumab, are associated with substantial improvements in skin inflammation and pruritus and demonstrate favorable safety profiles across diverse patient populations. Janus kinase inhibitors provide rapid symptom control but require careful patient selection due to safety considerations. Biomarkers such as thymus and activation-regulated chemokine, eotaxin-3, periostin, eosinophil count, and interleukin-13 gene expression contribute to the characterization of disease endotypes and may support biologically informed treatment decisions. Conclusions: Biologic and targeted systemic therapies have transformed the management of atopic dermatitis; however, optimal outcomes depend on individualized treatment selection. Biomarker-informed approaches offer a rational framework to reduce empirical treatment cycling and advance precision medicine in atopic dermatitis, although further validation in real-world clinical settings is required.

  • Open Access

    HEALTHCARE COSTS ACROSS THE BODY MASS INDEX SPECTRUM: THE ROLE OF AGE AND MULTIMORBIDITY — A SYSTEMATIC REVIEW

    by Małgorzata Dmochowska, Magdalena Wiśniewska, Paweł Jan Babiński, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger

    Background: Body mass index (BMI) is widely used to classify nutritional status and assess health risk at the population level. Both low and high BMI values are associated with adverse health outcomes; however, the economic consequences of abnormal BMI across the full BMI spectrum have not been comprehensively synthesized in recent literature. Objective: To systematically review evidence published since 2015 on healthcare costs associated with BMI categories ranging from underweight to severe obesity, with particular attention to the modifying roles of age and multimorbidity. Methods: A systematic literature search was conducted in PubMed to identify studies published between January 2015 and March 2025 reporting healthcare costs stratified by BMI. Observational studies, cohort studies, registry-based analyses, and cost-of-illness studies were included. Due to substantial methodological heterogeneity, a narrative synthesis was performed. Results: Across healthcare systems, a consistent non-linear association between BMI and healthcare costs was observed. Normal BMI was associated with the lowest expenditures, while both underweight and obesity were linked to increased costs. Severe obesity generated the highest costs, largely driven by chronic disease burden and hospitalization. Age and multimorbidity substantially modified the BMI–cost relationship, with underweight particularly associated with prolonged hospitalization among older adults. Conclusions: Healthcare costs vary significantly across the BMI spectrum. Both extremes of BMI are associated with increased economic burden, underscoring the importance of age-sensitive and multimorbidity-informed prevention and care strategies.

  • Open Access

    OPEN VERSUS LAPAROSCOPIC NEPHRECTOMY FOR RENAL TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PERIOPERATIVE, FUNCTIONAL AND ONCOLOGIC OUTCOMES

    by Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger

    Background: Renal tumors are increasingly detected early due to widespread imaging. For localized tumors, particularly stage T1, partial nephrectomy (PN) is the standard of care, offering oncological efficacy while preservingrenal function. Laparoscopic partial nephrectomy (LPN) has been increasingly adopted, yet comparative outcomes with open partial nephrectomy (OPN) remain actively evaluated. Aim: To systematically review perioperative, functional, and oncological outcomes of LPN versus OPN in patients with localized renal tumors, including the impact of tumor anatomical complexity. Materials and Methods: A systematic literature search of PubMed identified comparative studies of LPN versus OPN for T1–T1b renal tumors. Extracted data included operative time, estimated blood loss, complications, renalfunction, oncological outcomes, and tumor complexity assessed by nephrometry scores. Results: LPN showed perioperative advantages, including reduced blood loss and shorter hospital stay, with operative time generally comparable to OPN in experienced centers. Early and long-term renal function, measured by estimated glomerular filtration rate, was similar between approaches. Oncological outcomes, including positive surgical margins, recurrence-free survival, cancer-specific survival, and overall survival, were equivalent. In anatomically complex or selected T1b tumors, LPN achieved acceptable perioperative and oncological outcomes when performed in experienced centers. Conclusions: Laparoscopic partial nephrectomy is a safe and effective alternative to open surgery for localized renal tumors, offering perioperative benefits without compromising renal function or oncological control. Tumor complexity and patient characteristics are more influential determinants of outcomes than surgical approach. LPN should be considered a standard option in centers with expertise in minimally invasive nephron-sparing surgery.

  • Open Access

    FUSOBACTERIUM AS A POTENTIAL PATHOGENETIC FACTOR IN ENDOMETRIOSIS: CURRENT EVIDENCE, METHODOLOGICAL CHALLENGES, AND CLINICAL IMPLICATIONS

    by Julia Hertmanowska, Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger

    Background: Endometriosis is a chronic inflammatory gynecological disorder with an incompletely understood etiology. While hormonal, immunological, and genetic factors have been extensively studied, increasing attention has recently been directed toward the potential role of microbial agents in disease pathogenesis. Among these, Fusobacterium, particularly Fusobacterium nucleatum, has emerged as a candidate pathogen based on translational and experimental findings. Objective: This narrative review aims to critically evaluate current evidence regarding the association between Fusobacterium and endometriosis, assess the biological plausibility of a pathogenic role, and identify methodological limitations and clinical implications. Methods: A structured literature search was conducted in PubMed for publications addressing Fusobacterium in the context of endometriosis, including human studies, experimental models, and relevant commentaries. Evidence was synthesized thematically, with emphasis on study design, detection methods, and consistency of findings. Results: Available data suggest that Fusobacterium may be present in endometrial tissues of some women with endometriosis and may promote inflammatory signaling and lesion development in experimental models. However, recent human studies have reported conflicting results, including a lack of significant Fusobacterium enrichment in eutopic endometrium. These discrepancies appear to be influenced by differences in patient selection, sampling strategies, low-biomass contamination risk, and microbiological detection techniques. Conclusion: Although Fusobacterium represents a biologically plausible contributor to endometriosis pathophysiology, current evidence remains inconclusive. Further standardized, well-controlled studies are required before diagnostic or therapeutic strategies targeting this bacterium can be considered in clinical practice.

  • Open Access

    THE IMPACT OF CHRONIC STRESS ON MENSTRUAL DISORDERS IN WOMEN OF REPRODUCTIVE AGE: A LITERATURE REVIEW

    by Magdalena Wiśniewska, Paweł Jan Babiński, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger

    Chronic psychological and physical stress is a major contributor to menstrual disturbances in women of reproductive age. This review aims to synthesize current evidence on the mechanisms, clinical implications, and management of stress-related menstrual dysfunction, with particular focus on hypothalamic suppression. Methods included comprehensive evaluation of observational studies, clinical trials, and experimental research addressing neuroendocrine, metabolic, and behavioral pathways affected by prolonged stress, energy deficiency, and intensive physical activity. Findings indicate that chronic stress disrupts hormonal regulation by inhibiting gonadotropin secretion and impairing ovarian function, leading to reduced estrogen production and anovulation. Energy deficiency and excessive physical exertion exacerbate these effects, resulting in prolonged hypoestrogenism, impaired fertility, and decreased bone mineral density. Women affected may present with normal body weight, complicating early detection and diagnosis. Multidisciplinary management strategies, including lifestyle modification, nutritional support, moderated physical activity, and psychological interventions, have been shown to restore menstrual function and mitigate long-term complications. In selected cases, pharmacological interventions may be necessary to preserve bone health and support reproductive outcomes. Overall, stress-induced menstrual disorders result from a complex interplay between psychological, metabolic, and physical factors, requiring individualized assessment and treatment. Early identification and intervention are essential to prevent chronic health consequences, optimize reproductive potential, and maintain overall well-being. The review highlights gaps in understanding of individual susceptibility, recovery timelines, and long-term metabolic and cognitive outcomes, emphasizing the need for further research to develop targeted preventive and therapeutic strategies for women at risk of stress-related menstrual dysfunction.

  • Open Access

    SLEEP DISTURBANCES IN MAJOR DEPRESSIVE DISORDER: A COMPREHENSIVE NARRATIVE REVIEW

    by Adrianna Alicja Piekarska, Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Julia Hertmanowska, Marta Piotrowska, Krzysztof Chmura, Gabriela Kryger

    Objectives: To review and synthesize current evidence on the characteristics, underlying mechanisms, and clinical significance of sleep disturbances in Major Depressive Disorder (MDD). Methods: A narrative review of thirty peer-reviewed articles published between 2010 and 2025 was conducted. The included studies investigated sleep architecture, circadian rhythms, neurobiological mechanisms, and therapeutic interventions related to sleep disturbances in MDD using neuroimaging, electrophysiological, molecular, and clinical approaches. Results: The reviewed literature indicates that sleep disturbances are a core feature of MDD. The most consistently reported abnormalities include shortened rapid eye movement (REM) latency, reduced slow-wave sleep, and circadian rhythm dysregulation. These alterations are associated with dysfunctions of monoaminergic neurotransmission, hyperactivity of the hypothalamic-pituitary-adrenal axis, and disruptions of circadian clock gene regulation. Sleep disturbances were also linked to impairments in emotional regulation, cognitive functioning, metabolic processes, and treatment response. Sleep-focused interventions, including cognitive-behavioral therapy for insomnia, chronotherapy, and light-based treatments, demonstrated antidepressant effects. Conclusions: Sleep disturbances play a fundamental role in the pathophysiology and clinical course of MDD. Addressing sleep-related mechanisms may improve diagnostic accuracy, enhance treatment effectiveness, and contribute to better long-term outcomes in patients with depression.